Trane Technologies Other Income (Expense) increased by 169.2% to $15.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 293.7%, from -$7.90M to $15.30M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a 283.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $300.00K | -$6.90M | $14.90M | -$700.00K | -$1.60M | -$18.70M | -$2.30M | -$9.40M | -$57.40M | -$10.00M | -$15.40M | -$25.00M | -$4.10M | $6.30M | -$7.90M | -$14.10M | -$18.00M | -$22.10M | $15.30M |
| QoQ Change | — | <-999% | +315.9% | -104.7% | -128.6% | <-999% | +87.7% | -308.7% | -510.6% | +82.6% | -54.0% | -62.3% | +83.6% | +253.7% | -225.4% | -78.5% | -27.7% | -22.8% | +169.2% |
| YoY Change | — | — | — | — | -633.3% | -171.0% | -115.4% | <-999% | <-999% | +46.5% | -569.6% | -166.0% | +92.9% | +163.0% | +68.4% | -243.9% | -385.7% | — | +293.7% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Asia Pacific | $300.00K | $1.50M | -$900.00K | -$1.40M | $1.60M |
| EMEA | -$2.00M | -$5.20M | -$1.00M | -$1.90M | -$1.10M |
| Americas | -$2.20M | -$3.80M | -$9.60M | -$4.50M | $1.00M |
| Total | -$7.90M | -$14.10M | -$18.00M | -$22.10M | $15.30M |